What is the Terumo Corporation stock price forecast?

Terumo Corporation is currently trading at ¥2,237. View real-time AI analysis on Alpha Lenz.

What is Terumo Corporation insider trading activity?

View the latest insider trading data for Terumo Corporation on Alpha Lenz.

What is Terumo Corporation's P/E ratio?

Terumo Corporation's P/E ratio is 28.3.

Terumo Corporation

JPX · 4543

¥2,237+38(+1.70%)Market closed

Ask about Terumo Corporation's future dividend policy...

Alpha Chat Insight

“Terumo Corporation trades at a P/E of 28.3 (premium valuation) with solid ROE of 8.7%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”

Ask for details →

Company Overview

Terumo Corporation is a leading medical device and healthcare company that plays a significant role in the global health sector. Founded in 1921 and headquartered in Tokyo, Japan, Terumo specializes in the development, production, and distribution of a wide range of medical technologies and equipment. Its primary offerings include cardiovascular systems, blood management products, neuro-intervention devices, and general hospital equipment, highlighting its contribution to critical sectors such as cardiology, radiology, and blood transfusion services. Terumo’s cardiovascular products, including stents and catheters, are used extensively in minimally invasive procedures, which are crucial for patient recovery and healthcare efficiency. With a prominent presence in over 160 countries, Terumo Corporation is recognized for its commitment to medical innovation and healthcare improvements, showing a substantial impact on patient care and hospital management. The company continuously invests in research and development to expand its portfolio, ensuring state-of-the-art solutions that meet evolving medical needs worldwide.

CEOMr. Hikaru Samejima

Websitehttps://www.terumo.com

SectorHealthcare

IndustryMedical Instruments & Supplies

Employees30,207

Company Statistics

FY 2025

Profile

¥3,311,983,115,542Market Cap

¥1,036,171,000,000Revenue

0.00Shares Out

30,207Employees

Margins

54.11%Gross

23.77%EBITDA

15.22%Operating

14.92%Pre-Tax

11.29%Net

Valuation

28.31P/E

2.42P/B

3.20EV/Sales

13.26EV/EBITDA

25.79P/FCF

Growth (CAGR)

13.79%Rev 3Yr

10.50%Rev 5Yr

10.78%Op Inc 3Yr

7.35%Op Inc 5Yr

9.62%Net Inc 3Yr

6.59%Net Inc 5Yr

Returns

6.39%ROA

8.68%ROE

8.79%ROIC

Financial Health

¥221,872,000,000Cash & Cash Equivalents

¥237,986,000,000Net Debt

33.60%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Terumo Corporation trades at a P/E of 28.3 (premium valuation) with solid ROE of 8.7%. 3Y revenue CAGR of 13.8% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Terumo Corporation (ticker: 4543) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 30,207 employees. Market cap is $3.3T.

The current price is 2,237 with a P/E ratio of 28.31x and P/B of 2.42x.

ROE is 8.68% and operating margin is 15.22%. Annual revenue is $1.0T.